Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped down prior to trading on Friday . The stock had previously closed at $6.98, but opened at $6.82. Coloplast A/S shares last traded at $6.84, with a volume of 4,239 shares.

Analysts Set New Price Targets

Separately, Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Coloplast A/S Stock Performance

The company has a market capitalization of $15.54 billion, a P/E ratio of 36.28, a P/E/G ratio of 2.21 and a beta of 0.13. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75. The business’s fifty day simple moving average is $6.28 and its 200-day simple moving average is $6.64.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, meeting the consensus estimate of $0.10. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a net margin of 9.68% and a return on equity of 38.81%. As a group, equities analysts anticipate that Coloplast A/S Sponsored ADR will post 0.38 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.